Edap Tms S.A. (NASDAQ:EDAP) was downgraded by investment analysts at ValuEngine from a “hold” rating to a “sell” rating in a note issued to investors on Friday.

Other research analysts have also recently issued research reports about the stock. Zacks Investment Research cut shares of Edap Tms from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 29th. HC Wainwright reiterated a “buy” rating and set a $6.50 price objective on shares of Edap Tms in a research report on Monday, October 9th.

Edap Tms (NASDAQ:EDAP) traded down $0.01 during trading on Friday, reaching $2.92. 26,155 shares of the company were exchanged, compared to its average volume of 74,368. The stock has a market capitalization of $85.19, a P/E ratio of 73.25 and a beta of 1.05. The company has a current ratio of 2.96, a quick ratio of 2.35 and a debt-to-equity ratio of 0.11. Edap Tms has a 52 week low of $2.25 and a 52 week high of $3.85.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings results on Wednesday, August 23rd. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.02) by ($0.03). The business had revenue of $10.40 million for the quarter, compared to analysts’ expectations of $10.00 million. Edap Tms had a negative net margin of 0.27% and a positive return on equity of 10.31%. Edap Tms’s revenue for the quarter was up 13.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.10 EPS. sell-side analysts anticipate that Edap Tms will post -0.04 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This piece was posted by Watch List News and is owned by of Watch List News. If you are reading this piece on another website, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this piece can be accessed at https://www.watchlistnews.com/edap-tms-s-a-edap-downgraded-by-valuengine/1694314.html.

Hedge funds have recently bought and sold shares of the business. Archon Capital Management LLC bought a new position in Edap Tms during the second quarter valued at $2,474,000. Essex Investment Management Co. LLC bought a new position in Edap Tms during the second quarter valued at $172,000. Virtu KCG Holdings LLC bought a new position in Edap Tms during the second quarter valued at $117,000. Finally, Hilton Capital Management LLC increased its position in Edap Tms by 43.1% during the second quarter. Hilton Capital Management LLC now owns 83,000 shares of the medical equipment provider’s stock valued at $274,000 after acquiring an additional 25,000 shares during the last quarter. Institutional investors and hedge funds own 10.20% of the company’s stock.

About Edap Tms

EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.

Receive News & Ratings for Edap Tms S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms S.A. and related companies with Analyst Ratings Network's FREE daily email newsletter.